{
  "experiment_id": "ba60fe1531d9f26640f881fdf280d081",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-11-15T02:39:58.897624",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"Neurofibromatosis\" (broad term) \u2192 \"Neurofibromatosis type 1\" (more specific). This is the most common form of neurofibromatosis and matches the controlled terminology in the schema.\n\n2. **assay**: \"DNA sequencing\" (broad term) \u2192 \"whole genome sequencing\" (more specific). This narrows the general DNA sequencing method to a specific type that is commonly used and matches the controlled terminology.\n\n3. **tumorType**: \"Neurofibroma\" remains unchanged as it already matches an exact value in the controlled terminology and is appropriately specific for this context.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3029,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 206
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01U7DdNwumyqJpYtfHt6smBU",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"Neurofibromatosis\" (broad term) \u2192 \"Neurofibromatosis type 1\" (more specific). This is the most common form of neurofibromatosis and matches the controlled terminology in the schema.\n\n2. **assay**: \"DNA sequencing\" (broad term) \u2192 \"whole genome sequencing\" (more specific). This narrows the general DNA sequencing method to a specific type that is commonly used and matches the controlled terminology.\n\n3. **tumorType**: \"Neurofibroma\" remains unchanged as it already matches an exact value in the controlled terminology and is appropriately specific for this context."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3029,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 206
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3029,
          "output_tokens": 206,
          "total_tokens": 3235
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3023,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 54
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01SguCCpaFLT11ohmYsgRry8",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3023,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 54
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3023,
          "output_tokens": 54,
          "total_tokens": 3077
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3038,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 62
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01H64xKZMPXRryja4Yu7JGDJ",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3038,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 62
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3038,
          "output_tokens": 62,
          "total_tokens": 3100
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" is a broad term that encompasses several conditions. Based on the available controlled terminology, \"Neurofibromatosis type 1\" is the most common and representative neurocutaneous syndrome in the schema. (Note: If more context were available, other options like \"NF2-related schwannomatosis\" or \"Schwannomatosis\" could also be appropriate neurocutaneous syndromes.)\n\n2. **assay**: \"spectroscopy\" is a broad term. From the controlled terminology, \"FTIR spectroscopy\" (Fourier-Transform Infrared Spectroscopy) is the specific spectroscopy method available in the schema.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled terminology enum values.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3023,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 245
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01KjN8Zd6xXtUksAnpSyn46c",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" is a broad term that encompasses several conditions. Based on the available controlled terminology, \"Neurofibromatosis type 1\" is the most common and representative neurocutaneous syndrome in the schema. (Note: If more context were available, other options like \"NF2-related schwannomatosis\" or \"Schwannomatosis\" could also be appropriate neurocutaneous syndromes.)\n\n2. **assay**: \"spectroscopy\" is a broad term. From the controlled terminology, \"FTIR spectroscopy\" (Fourier-Transform Infrared Spectroscopy) is the specific spectroscopy method available in the schema.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled terminology enum values."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3023,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 245
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3023,
          "output_tokens": 245,
          "total_tokens": 3268
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `diagnosis`: \"Not Applicable\" - No change needed (already matches exact enum value)\n- `assay`: \"immunoassay\" - No change needed (already matches exact enum value)\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" - Corrected capitalization to match the exact controlled terminology value in the Target Schema",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3025,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 134
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01UC3Fvt1qUhm7VRde2f12f9",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `diagnosis`: \"Not Applicable\" - No change needed (already matches exact enum value)\n- `assay`: \"immunoassay\" - No change needed (already matches exact enum value)\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" - Corrected capitalization to match the exact controlled terminology value in the Target Schema"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3025,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 134
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3025,
          "output_tokens": 134,
          "total_tokens": 3159
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3031,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 56
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01CHC24RphFRyocb3xTyLPJy",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 56
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 56,
          "total_tokens": 3087
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"RASopathy\" is a broad term referring to a group of genetic syndromes caused by mutations in the RAS/MAPK pathway. I narrowed this to \"Noonan Syndrome\", which is one of the most common RASopathies and is included in the controlled terminology.\n\n2. **assay**: \"immunoassay\" is already a specific term in the controlled vocabulary and matches exactly, so no change was needed.\n\n3. **tumorType**: \"NFIB\" appears to be an abbreviation or broad reference. Based on the context and available controlled terminology, I narrowed this to \"Neurofibroma\", which is a specific tumor type commonly associated with neurofibromatosis conditions.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3026,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 222
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_019sGLLDWU3DzpDnH4boe1Kf",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"RASopathy\" is a broad term referring to a group of genetic syndromes caused by mutations in the RAS/MAPK pathway. I narrowed this to \"Noonan Syndrome\", which is one of the most common RASopathies and is included in the controlled terminology.\n\n2. **assay**: \"immunoassay\" is already a specific term in the controlled vocabulary and matches exactly, so no change was needed.\n\n3. **tumorType**: \"NFIB\" appears to be an abbreviation or broad reference. Based on the context and available controlled terminology, I narrowed this to \"Neurofibroma\", which is a specific tumor type commonly associated with neurofibromatosis conditions."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3026,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 222
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3026,
          "output_tokens": 222,
          "total_tokens": 3248
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" is a broad abbreviation that could refer to multiple neurofibromatosis conditions. I narrowed it to \"Neurofibromatosis type 1\" as this is the most common form of NF and the most likely intended value when \"NF\" is used generically.\n\n2. **assay**: \"medical imaging\" is a very broad term. I narrowed it to \"conventional MRI\" as this is the most commonly used medical imaging modality in neurofibromatosis research and clinical practice for tumor detection and monitoring.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact controlled terminology value in the Target Schema (with capital \"U\").",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3019,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 217
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01SdPhAajXMsKXoru5W8XeNG",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" is a broad abbreviation that could refer to multiple neurofibromatosis conditions. I narrowed it to \"Neurofibromatosis type 1\" as this is the most common form of NF and the most likely intended value when \"NF\" is used generically.\n\n2. **assay**: \"medical imaging\" is a very broad term. I narrowed it to \"conventional MRI\" as this is the most commonly used medical imaging modality in neurofibromatosis research and clinical practice for tumor detection and monitoring.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact controlled terminology value in the Target Schema (with capital \"U\")."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3019,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 217
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3019,
          "output_tokens": 217,
          "total_tokens": 3236
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad term referring to disorders of neural crest-derived tissues. Since the most common neurocristopathy in the provided enum is Neurofibromatosis type 1 (NF1), which affects neural crest-derived cells and is well-represented in the schema, this is the most appropriate narrowed term.\n\n2. **assay**: \"transcriptomics\" is already present in the Target Schema enum as an exact match, so no change was needed.\n\n3. **tumorType**: \"neurolemmoma\" is a synonym for schwannoma (a tumor arising from Schwann cells). The exact controlled term in the schema is \"Schwannoma\", so this broad/alternative term was narrowed to the precise controlled vocabulary term.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3027,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 237
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01LVCyvDXvh7rzTudy6uG7w1",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad term referring to disorders of neural crest-derived tissues. Since the most common neurocristopathy in the provided enum is Neurofibromatosis type 1 (NF1), which affects neural crest-derived cells and is well-represented in the schema, this is the most appropriate narrowed term.\n\n2. **assay**: \"transcriptomics\" is already present in the Target Schema enum as an exact match, so no change was needed.\n\n3. **tumorType**: \"neurolemmoma\" is a synonym for schwannoma (a tumor arising from Schwann cells). The exact controlled term in the schema is \"Schwannoma\", so this broad/alternative term was narrowed to the precise controlled vocabulary term."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3027,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 237
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3027,
          "output_tokens": 237,
          "total_tokens": 3264
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of narrowing decisions:**\n\n1. **diagnosis**: \"phakomatosis\" \u2192 \"Neurofibromatosis type 1\"\n   - Phakomatosis is a broad term for neurocutaneous syndromes. Among the available options in the schema, Neurofibromatosis type 1 is the most common phakomatosis and represents a specific narrowing of this general term.\n\n2. **assay**: \"viability assay\" \u2192 \"cell viability assay\"\n   - The broad term \"viability assay\" is narrowed to the more specific \"cell viability assay\" which is an exact match in the controlled terminology.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" \u2192 \"Schwannoma\"\n   - This broad anatomical description is narrowed to \"Schwannoma,\" which is the most common tumor type affecting cranial and spinal nerves and is available in the controlled vocabulary.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3031,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 271
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_017vyALxne1eXdxbhUZWQXaB",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of narrowing decisions:**\n\n1. **diagnosis**: \"phakomatosis\" \u2192 \"Neurofibromatosis type 1\"\n   - Phakomatosis is a broad term for neurocutaneous syndromes. Among the available options in the schema, Neurofibromatosis type 1 is the most common phakomatosis and represents a specific narrowing of this general term.\n\n2. **assay**: \"viability assay\" \u2192 \"cell viability assay\"\n   - The broad term \"viability assay\" is narrowed to the more specific \"cell viability assay\" which is an exact match in the controlled terminology.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" \u2192 \"Schwannoma\"\n   - This broad anatomical description is narrowed to \"Schwannoma,\" which is the most common tumor type affecting cranial and spinal nerves and is available in the controlled vocabulary."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 271
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 271,
          "total_tokens": 3302
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4666666666666667,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 52.26191854476929,
    "token_usage": {
      "input_tokens": 30272,
      "output_tokens": 1704,
      "total_tokens": 31976
    }
  }
}